You just read:

Biohaven's NURTEC™ ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

Feb 27, 2020, 16:11 ET